Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena R. Chang

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cancer|January 22, 2009
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapyRaquel Prati, Christina A Minami, Jeff A Gornbein, et al.
Cancer Research|March 22, 2003
Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccineMaureen A Chung, Yi Luo, Michael O'Donnell, et al.
Briefings in Functional Genomics & Proteomics|July 9, 2004
Proteomic profiling of cancer biomarkersHungyi Shau, G Scott Chandler, Julian P Whitelegge, et al.
International Journal of Proteomics|December 6, 2014
Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancerXinyu Deng, Morris Kohanfars, Huan Ming Hsu, et al.
Biomarker Insights|August 8, 2009
Proteomics and mass spectrometry for cancer biomarker discoveryMing Lu, Kym F Faull, Julian P Whitelegge, et al.
Cancer|June 16, 2010
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatmentHelena R Chang, John Glaspy, Mary Ann Allison, et al.
Journal of Proteomics & Bioinformatics|July 3, 2010
Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast CancerMing Lu, Julian P Whitelegge, Stephen A Whelan, et al.
Clinical Proteomics|October 9, 2010
Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass SpectrometerMing Lu, Stephen A Whelan, Jianbo He, et al.
International Journal of Oncology|September 3, 2009
Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapyJianbo He, Dejun Shen, Debra U Chung, et al.
Biomed Research International|September 10, 2015
The Effect of Young Age in Hormone Receptor Positive Breast CancerMinna K Lee, Leo A Varzi, Debra U Chung, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cancer|January 22, 2009
Accuracy of clinical evaluation of locally advanced breast cancer in patients receiving neoadjuvant chemotherapyRaquel Prati, Christina A Minami, Jeff A Gornbein, et al.
Cancer Research|March 22, 2003
Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccineMaureen A Chung, Yi Luo, Michael O'Donnell, et al.
Briefings in Functional Genomics & Proteomics|July 9, 2004
Proteomic profiling of cancer biomarkersHungyi Shau, G Scott Chandler, Julian P Whitelegge, et al.
International Journal of Proteomics|December 6, 2014
Combined phosphoproteomics and bioinformatics strategy in deciphering drug resistant related pathways in triple negative breast cancerXinyu Deng, Morris Kohanfars, Huan Ming Hsu, et al.
Biomarker Insights|August 8, 2009
Proteomics and mass spectrometry for cancer biomarker discoveryMing Lu, Kym F Faull, Julian P Whitelegge, et al.
Cancer|June 16, 2010
Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatmentHelena R Chang, John Glaspy, Mary Ann Allison, et al.
Journal of Proteomics & Bioinformatics|July 3, 2010
Hydrophobic Fractionation Enhances Novel Protein Detection by Mass Spectrometry in Triple Negative Breast CancerMing Lu, Julian P Whitelegge, Stephen A Whelan, et al.
Clinical Proteomics|October 9, 2010
Hydrophobic Proteome Analysis of Triple Negative and Hormone-Receptor-Positive-Her2-Negative Breast Cancer by Mass SpectrometerMing Lu, Stephen A Whelan, Jianbo He, et al.
International Journal of Oncology|September 3, 2009
Tumor proteomic profiling predicts the susceptibility of breast cancer to chemotherapyJianbo He, Dejun Shen, Debra U Chung, et al.
Biomed Research International|September 10, 2015
The Effect of Young Age in Hormone Receptor Positive Breast CancerMinna K Lee, Leo A Varzi, Debra U Chung, et al.
Pageof 4